Oral submucous fibrosis (OSF) is a progressive scarring disease. has been reported as a tumour suppressor, but its role in the precancerous OSF remains unknown. In this study, we investigated the impact of miR-200b on myofibroblastic differentiation activity. Arecoline is a major areca nut alkaloid and has been employed to induce the elevated myofibroblast activity in human buc- 
| INTRODUCTION
Oral submucous fibrosis (OSF) is a chronic progressive scarring disease and has been recognized as one of the oral potentially malignant disorders. This precancerous condition of the oral mucosa is associated with inflammatory cell infiltration followed by the accumulation of connective tissue in lamina propria and epithelial atrophy, 1, 2 leading to difficulty of mouth opening. Epidemiological evidence has attributed areca quid chewing habit as the main aetiological factor for OSF. 3, 4 However, the precise pathogenesis of OSF still remains elusive and effective treatment is lacking.
Myofibroblasts, the a-smooth muscle actin (SMA)-expressing contractile fibroblasts, 5 play a critical role in wound healing and tissue remodelling. 6 However, persistent activation of myofibroblasts often leads to pathological fibrosis as it has been implicated in the dysregulation of extracellular matrix (ECM) synthesis and degradation. 6, 7 Myofibroblast accumulation indeed has been found in multiple tissue fibroses, including OSF. 8 Among multiple sources of myofibroblast precursors, it has been indicated that epithelialmesenchymal transition (EMT) contributes to tissue fibroses. 6, 7, 9 motile mesenchymal cells, and it is mediated by various key transcription factors, including Snail (SNAI1), Slug (SNAI2), zinc-finger E-box-binding (ZEB) and other basic helix-loop-helix transcription factors. 10, 11 Also, intermediate filaments, such as vimentin, play a critical role in the induction of mesenchymal cell shape and motile behaviour. 12 Our previous findings have shown that arecolineinduced myofibroblast transdifferentiation is mediated by ZEB1, 13 and inhibition of EMT transcription factor suppressed the pathogenesis of areca quid-induced OSF through down-regulation of myofibroblast activity. 14 Hence, approaches to decrease the EMT regulating factors may be a promising strategy to inhibit the activation of myofibroblasts after arecoline stimulation, therefore preventing OSF pathogenesis. 27 Hence, the impact of miR-200b on precancerous OSF needs to be clarified.
In this study, we explored the functional role of miR-200b in the pathogenesis of areca quid-associated OSF and the associated mech- 
| MATERIALS AND METHODS

| Chemicals and cell culture
Arecoline and collagen solution from bovine skin were purchased grown and maintained by using the explant method as described previously. 28 Cell cultures between the third and eighth passages were used in this study. 2 9 10 5 BMFs were suspended in 0.5 mL of 2 mg/mL collagen solution (Sigma-Aldrich) and then added into 24-well plate followed by incubation at 37°C for 2 hours for the polymerization of collagen cell gels. After detaching gels from wells, the gels were further incubated in 0.5 mL MEMa medium with or without arecoline for 48 hours.
| Collagen contraction assay
Contraction of the gels was photographed and measured using ImageJ software (NIH) to calculate their areas. 
| Migration assay
Cell migration assay was conducted using 24-well plate Transwell â system with a polycarbonate filter membrane of 8-lm pore size (Corning, Acton, MA, USA) assay kit as previously described. 30 The migrated cancer cells were then visualized and counted from 5 randomly selected fields under 100-fold magnification using an inverted microscope.
| Wound healing assay
Cells were seeded into 6-well culture dishes. Wounds were introduced to the confluent monolayer of cells with a sterile 200 lL plastic pipette tip to create a denuded area. Cell movement towards the centre of the wound area was photographed at 0 and 48 hours under a microscope. 14 
| Western blot analysis
Western blot analysis was conducted as previously described. MiR-200b overexpression plasmid construct was generated according to our previous method. 
| Apoptotic assay
| Statistical analysis
Quantitative data were presented as mean AE SD and analysed with Student's t test performed with SPSS Statistics version 13.0. P value < .05 was considered as statistically significant.
| RESULTS
| Mir-200b is significantly down-regulated in arecoline-stimulated BMFs and fBMFs
Arecoline is a major areca nut alkaloid and has been implicated in the pathogenesis of OSF. 3 Our previous study has demonstrated that arecoline could induce myofibroblast transdifferentiation in human primary buccal mucosal fibroblasts (BMFs). 13 
| Overexpression of miR-200b successfully hinders the arecoline-induced myofibroblast activities
Upon injury, fibroblasts become activated to migrate into the injured site and differentiate into contractile myofibroblasts for tissue healing. 6 It also has been demonstrated that treatment of areca nut extract dose-dependently increases the collagen contractility. 31 Therefore, collagen gel contraction and migration capacities have been commonly employed to study the activity of myofibroblasts. 14, 29 As expected, BMFs exhibited increased contractility in response to arecoline exposure, whereas overexpression of miR200b counteracted it (Figure 2A ). In addition, we observed that the arecoline-enhanced migration activity of BMFs was repressed by overexpression of miR-200b ( Figure 2B ).
| MiR-200b reduces the characteristics of myofibroblasts
To confirm the role of miR-200b in myofibroblast activation, we investigated whether these increased activities and myofibroblast marker, a-SMA, would be suppressed by elevated expression of miR200b. By collagen contraction assay, we demonstrated that overexpression of miR-200b significantly inhibited the highly contractile phenotype in BMFs from fibrotic oral cavity tissues ( Figure 3A ).
With regard to the impact of miR-200b on their migration capacity,
we observed a decreased cell migration performed with transwell ( Figure 3B ) and wound healing ( Figure 3C ) assays. Moreover, we
showed that miR-200b reduced the expression level of a-SMA, indicating the anti-fibrotic effect of miR-200b ( Figures 3D and S1 ).
| MiR-200b directly targets ZEB2 and mediates
ZEB2-regulated expression of a-SMA and vimentin in fBMFs
As a direct target of miR-200b, Figures 5A and S4) . Nevertheless, the increased expression levels of Slug and a-SMA were abolished by knockdown of ZEB2 ( Figure 5A ). We showed that silencing of endogenous miR-200b induced higher migration ability (
Figure 5B), collagen gel contractility ( Figure 5C ) and wound healing capacity ( Figure 5D ) in BMFs, whereas knockdown of ZEB2 counteracted these responses (Figure 5B-D) . Altogether, these findings suggested that blockage of the endogenous miR-200b resulted in increased expression of Slug and a-SMA via ZEB2 in BMFs, leading to increased myofibroblast activity. Over the past few years, the mechanism for the anti-fibrotic effects of miR-200b has been examined and discussed in several fibrotic diseases. It has been shown that miR-200b ameliorated TGFb1-induced fibrosis in colorectal epithelial cells. 37 In hypertrophic scars, miR-200b has been proved to decrease the expression of fibrosis markers, such as collagen type 1 and a-SMA, as well as ZEB1 in fibroblasts. 38 Another study showed that miR-200b affected hypertrophic scarring through regulating the fibroblasts proliferation and apoptosis by affecting the collagen synthesis, fibronectin expression and TGF-b1/a-SMA signalling. 39 As for pulmonary fibrosis, it has been found that the expression of miR-200 was reduced in fibrotic lungs, and down-regulation of miR-200 may contribute to EMT and enhance pulmonary fibroblast accumulation. 22 In contrast, 
| Overexpression of miR-200b expression induces apoptosis in fBMFs
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